GMED
Price
$61.28
Change
+$0.15 (+0.25%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
8.26B
74 days until earnings call
PAVM
Price
$0.49
Change
+$0.02 (+4.26%)
Updated
Aug 29, 04:57 PM (EDT)
Capitalization
10.64M
Interact to see
Advertisement

GMED vs PAVM

Header iconGMED vs PAVM Comparison
Open Charts GMED vs PAVMBanner chart's image
Globus Medical
Price$61.28
Change+$0.15 (+0.25%)
Volume$10.48K
Capitalization8.26B
PAVmed
Price$0.49
Change+$0.02 (+4.26%)
Volume$179
Capitalization10.64M
GMED vs PAVM Comparison Chart in %
Loading...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMED vs. PAVM commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a StrongBuy and PAVM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (GMED: $61.13 vs. PAVM: $0.47)
Brand notoriety: GMED and PAVM are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GMED: 51% vs. PAVM: 72%
Market capitalization -- GMED: $8.26B vs. PAVM: $10.26M
GMED [@Medical/Nursing Services] is valued at $8.26B. PAVM’s [@Medical/Nursing Services] market capitalization is $10.26M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whilePAVM’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • PAVM’s FA Score: 0 green, 5 red.
According to our system of comparison, both GMED and PAVM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 5 TA indicator(s) are bullish while PAVM’s TA Score has 4 bullish TA indicator(s).

  • GMED’s TA Score: 5 bullish, 5 bearish.
  • PAVM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GMED and PAVM are a good buy in the short-term.

Price Growth

GMED (@Medical/Nursing Services) experienced а +1.04% price change this week, while PAVM (@Medical/Nursing Services) price change was +11.19% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.88%. For the same industry, the average monthly price growth was +6.74%, and the average quarterly price growth was +10.13%.

Reported Earning Dates

GMED is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.88% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($8.26B) has a higher market cap than PAVM($10.6M). GMED has higher P/E ratio than PAVM: GMED (23.75) vs PAVM (0.11). PAVM (-25.418) and GMED (-26.091) have similar YTD gains . GMED has higher annual earnings (EBITDA): 620M vs. PAVM (68.6M). GMED has more cash in the bank: 229M vs. PAVM (4M). PAVM has less debt than GMED: PAVM (9.31M) vs GMED (121M). GMED has higher revenues than PAVM: GMED (2.63B) vs PAVM (1.02M).
GMEDPAVMGMED / PAVM
Capitalization8.26B10.6M77,887%
EBITDA620M68.6M904%
Gain YTD-26.091-25.418103%
P/E Ratio23.750.1122,378%
Revenue2.63B1.02M257,451%
Total Cash229M4M5,719%
Total Debt121M9.31M1,300%
FUNDAMENTALS RATINGS
GMED vs PAVM: Fundamental Ratings
GMED
PAVM
OUTLOOK RATING
1..100
7980
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5789
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAVM's Valuation (58) in the Medical Specialties industry is in the same range as GMED (75). This means that PAVM’s stock grew similarly to GMED’s over the last 12 months.

GMED's Profit vs Risk Rating (77) in the Medical Specialties industry is in the same range as PAVM (100). This means that GMED’s stock grew similarly to PAVM’s over the last 12 months.

GMED's SMR Rating (100) in the Medical Specialties industry is in the same range as PAVM (100). This means that GMED’s stock grew similarly to PAVM’s over the last 12 months.

GMED's Price Growth Rating (57) in the Medical Specialties industry is in the same range as PAVM (89). This means that GMED’s stock grew similarly to PAVM’s over the last 12 months.

GMED's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as PAVM (100). This means that GMED’s stock grew similarly to PAVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDPAVM
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
65%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CNPCX66.410.29
+0.44%
American Funds New Perspective 529C
ACGKX22.62N/A
N/A
Invesco Growth and Income C
MLORX9.05N/A
N/A
Cohen & Steers Future of Energy R
FEQNX14.36N/A
N/A
Fidelity Advisor Hedged Equity Fund M
JDSRX22.98-0.05
-0.22%
Janus Henderson Small Cap Value R

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.62%
VREX - GMED
52%
Loosely correlated
+0.17%
CVRX - GMED
49%
Loosely correlated
+4.23%
CTKB - GMED
49%
Loosely correlated
+1.96%
ITGR - GMED
45%
Loosely correlated
-0.64%
TMCI - GMED
44%
Loosely correlated
-0.27%
More

PAVM and

Correlation & Price change

A.I.dvisor tells us that PAVM and GMED have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PAVM and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAVM
1D Price
Change %
PAVM100%
-2.90%
GMED - PAVM
26%
Poorly correlated
-0.62%
CVRX - PAVM
25%
Poorly correlated
+4.23%
RVTY - PAVM
25%
Poorly correlated
+0.72%
CSTL - PAVM
24%
Poorly correlated
+5.30%
LUCD - PAVM
23%
Poorly correlated
-4.76%
More